C1 domain residues Lys 2092 and Phe 2093 are of major importance for the endocytic uptake of coagulation factor VIII

被引:34
作者
Meems, Henriet [1 ,2 ]
van den Biggelaar, Maartje [1 ]
Rondaij, Mariska [1 ]
van der Zwaan, Carmen [1 ]
Mertens, Koen [1 ,2 ,3 ]
Meijer, Alexander B. [1 ,3 ]
机构
[1] Sanquin Res, Dept Plasma Prot, NL-1066 CX Amsterdam, Netherlands
[2] UMC Utrecht & Sanquin, Van Creveld Lab, Amsterdam, Netherlands
[3] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands
关键词
Factor VIII; Low-density lipoprotein receptor-related protein (LRP); Endocytosis; Cell surface binding; Flow cytometry; DENSITY-LIPOPROTEIN RECEPTOR; VON-WILLEBRAND-FACTOR; PLASMINOGEN-ACTIVATOR INHIBITOR-1; HEMOPHILIA-A; BINDING-SITE; LIGAND RECOGNITION; LIGHT-CHAIN; RAP COMPLEX; FACTOR IXA; PROTEIN;
D O I
10.1016/j.biocel.2011.03.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Factor VIII (FVIII) catabolism has been demonstrated to involve LDL receptor-related protein (LRP). We have established that antibody fragment KM33 inhibits cofactor function of FVIII by interacting with the membrane binding region 2092-2093 of the C1 domain. As KM33 also inhibits LRP-dependent uptake of FVIII, we now assessed the role of region 2092-2093 for LRP-dependent endocytosis. For this purpose, we employed functional fluorescent FVIII-YFP or -GFP derivatives and U87MG cells which express high levels of LRP. Confocal microscopy studies and flow cytometry analysis combined with siRNA technology showed that the fluorescent FVIII derivatives are indeed effectively internalized by U87MG cells in a LRP-dependent manner. Competition experiments employing an antagonist of the LDL receptor family members revealed that there is a cell surface binding event for FVIII, which is independent of LRP. Cell surface binding proved to be less effective for the FVIII-YFP variants K2092A. F2093A and K2092A/F2093A. Surface plasmon resonance analysis showed that these substitutions affect LRP binding as well. Finally, flow cytometry analysis revealed a major reduction of endocytic uptake of these FVIII-YFP variants. Our results demonstrate that C1 domain residues 2092-2093 are of major importance for FVIII endocytosis by contributing to cell surface binding and receptor binding. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1114 / 1121
页数:8
相关论文
共 37 条
[1]   The binding sites for the very low density lipoprotein receptor and low-density lipoprotein receptor-related protein are shared within coagulation factor VIII [J].
Ananyeva, Natalya M. ;
Makogonenko, Yevgen M. ;
Kouiavskaia, Diana V. ;
Ruiz, Jose ;
Limburg, Vincent ;
Meijer, Alexander B. ;
Khrenov, Alexey V. ;
Shima, Midori ;
Strickland, Dudley K. ;
Saenko, Evgueni L. .
BLOOD COAGULATION & FIBRINOLYSIS, 2008, 19 (02) :166-177
[2]   Versatility in ligand recognition by LDL receptor family proteins: advances and frontiers [J].
Blacklow, Stephen C. .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 2007, 17 (04) :419-426
[3]   Proteolytic cleavage of factor VIII heavy chain is required to expose the binding-site for low-density lipoprotein receptor-related protein within the A2 domain [J].
Bovenschen, N. ;
Van Stempvoort, G. ;
Voorberg, J. ;
Mertens, K. ;
Meijer, A. B. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (07) :1487-1493
[4]   LDL receptor cooperates with LDL receptor-related protein in regulating plasma levels of coagulation factor VIII in vivo [J].
Bovenschen, N ;
Mertens, K ;
Hu, LH ;
Havekes, LM ;
van Vlijmen, BJM .
BLOOD, 2005, 106 (03) :906-912
[5]   Clearance of coagulation factor VIII in very low-density lipoprotein receptor knockout mice [J].
Bovenschen, N ;
Dijk, KW ;
Havekes, LM ;
Mertens, K ;
Vlijmen, BJM .
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 126 (05) :722-725
[6]   The B domain of coagulation factor VIII interacts with the asialoglycoprotein receptor [J].
Bovenschen, N ;
Rijken, DC ;
Havekes, LM ;
Van Vlijmen, BJM ;
Mertens, K .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (06) :1257-1265
[7]   Low density lipoprotein receptor-related protein and factor IXa share structural requirements for binding to the A3 domain of coagulation factor VIII [J].
Bovenschen, N ;
Boertjes, RC ;
van Stempvoort, G ;
Voorberg, J ;
Lenting, PJ ;
Meijer, AB ;
Mertens, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (11) :9370-9377
[8]   Elevated plasma factor VIII in a mouse model of low-density lipoprotein receptor-related protein deficiency [J].
Bovenschen, N ;
Herz, J ;
Grimbergen, JM ;
Lenting, PJ ;
Havekes, LM ;
Mertens, K ;
van Viijmen, BJM .
BLOOD, 2003, 101 (10) :3933-3939
[9]   PURIFIED HUMAN FACTOR-VIII PROCOAGULANT PROTEIN - COMPARATIVE HEMOSTATIC RESPONSE AFTER INFUSIONS INTO HEMOPHILIC AND VONWILLEBRAND DISEASE DOGS [J].
BRINKHOUS, KM ;
SANDBERG, H ;
GARRIS, JB ;
MATTSSON, C ;
PALM, M ;
GRIGGS, T ;
READ, MS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (24) :8752-8756
[10]   Factor VIII bypasses CD91/LRP for endocytosis by dendritic cells leading to T-cell activation [J].
Dasgupta, Suryasarathi ;
Navarrete, Ana Maria ;
Andre, Sebastien ;
Wootla, Bharath ;
Delignat, Sandrine ;
Repesse, Yohann ;
Bayry, Jagadeesh ;
Nicoletti, Antonino ;
Saenko, Evgueni L. ;
d'Oiron, Roseline ;
Jacquemin, Marc ;
Saint-Remy, Jean-Marie ;
Kaveri, Srini, V ;
Lacroix-Desmazes, Sebastien .
HAEMATOLOGICA, 2007, 93 (01) :83-89